Objective: Ischemic mitral regurgitation can be treated with a restrictive mitral annuloplasty, with or without coronary revascularization. In this study, the extent of reverse remodeling of the left ventricle following this strategy is assessed, as well as the factors that influence it. Methods: Eighty-seven consecutive patients with ischemic mitral regurgitation and a mean ejection fraction of 32G10% underwent restrictive mitral annuloplasty (downsizing by two ring sizes, median ring size 26), with additional coronary revascularization in 75 patients. All underwent transthoracic echocardiography 18 months after surgery to assess residual mitral regurgitation, mitral valve gradient and left ventricular endsystolic and end-diastolic dimensions. Univariate and multivariate analysis was performed to identify predictors for reverse remodeling, defined as a 10% reduction in left ventricular dimension. Receiver-operating characteristic analysis was used to identify cut-off values for preoperative left ventricular dimensions in predicting reverse remodeling. Results: Early mortality was 8.0% (seven patients, three non-cardiac), late mortality was 7.5% (six patients, four non-cardiac). There were two reoperations (redo annuloplasty), and four readmissions for heart failure. At 29 months follow-up, NYHA class improved from 3.0G0.9 to 1.3G0.5 (P!0.01). Mitral regurgitation grade decreased from 3.1G0.5 to 0.6G0.6 at 18 months, left ventricular end-systolic dimension decreased from 52G8 to 44G11 mm (P!0.01), and end-diastolic dimension from 64G8 to 58G10 mm (P!0.01). Multivariate analysis identified preoperative left ventricular end-diastolic dimension as the single best factor in predicting occurrence of reverse remodeling. For end-systolic dimension, 51 mm was the optimal cut-off value to predict reverse remodeling (specificity and sensitivity 81%, area under curve 0.85); for end-diastolic dimension, the cut-off value was 65 mm (specificity and sensitivity 89%, area under curve 0.92). Conclusions: Stringent restrictive mitral annuloplasty with or without revascularization provides excellent clinical results with acceptable mortality. At 18 months follow-up, there is no significant residual mitral regurgitation. Reverse remodeling occurs in the majority of patients, but is limited by preoperative left ventricular dimensions. In patients with a left ventricular end-diastolic dimension exceeding 65 mm, additional surgical procedures are necessary to try and obtain reverse remodeling in this subgroup. q
Introduction
Chronic ischemic mitral regurgitation (IMR) should be defined as mitral regurgitation (MR) resulting from coronary artery disease (CAD) [1, 2] . This definition excludes all cases in which MR merely coincides with CAD. Regional wall motion abnormalities secondary to ischemia, whether persistentfollowing myocardial infarction-or transient, give rise to functional MR [3] . Echocardiographically, functional MR is characterized by leaflet coaptation failure due to systolic restrictive motion of one or both valve leaflets (Carpentier type IIIb [4] ), often combined with annular dilatation.
In the past, revascularization alone was believed to correct IMR by improving LV function [5, 6] . This may seem attractive, since isolated CABG carries a lower peri-operative risk than a combined procedure. Nowadays, there are convincing arguments that negate a conservative approach.
First, IMR is not a benign condition, but instead carries a two-fold excess mortality of 62% at 5 years in post-infarction patients irrespective of other risk factors [1] . In addition, it is a progressive disorder in which MR-related LV volume overload promotes further LV remodeling, leading to worsening of MR. Follow-up in moderate chronic IMR patients has shown that isolated CABG does not always cure MR [7] . Intervention on the mitral valve can be limited to a stringent 'restrictive' (down-sized) ring annuloplasty, which is a relatively simple technique with an acceptable mortality even in high-risk end-stage heart failure patients with dilated cardiomyopathy [8] .
There is still controversy regarding the outcome of chronic IMR patients treated with combined CABG and restrictive mitral annuloplasty (RMA). We describe our experience with this approach in 87 consecutive patients with respect to clinical outcome and echocardiographic follow-up. We focus on durability of the annuloplasty technique by assessment of MR, and on LV reverse remodeling, especially in relation to the extent of preoperative LV dilatation. In an earlier report [9] we demonstrated that not all patients show reverse remodeling following successful RMA with or without CABG. In this study, we assessed the influence (and predictive value of) several preoperative variables on reverse LV remodeling.
Materials and methods

Patient population
Between January 2000 and March 2004, 87 consecutive patients with chronic ischemic mitral regurgitation underwent coronary revascularization and restrictive mitral annuloplasty. Mean age was 66.0G10.0 years (range 36.8-84.6 years), and 57 (65.5%) patients were male. All patients had coronary artery disease and previous myocardial infarction. Patients with signs and symptoms of heart failure and/or evidence of mitral regurgitation on LV angiography underwent preoperative transthoracic echocardiography (TTE) to assess severity of MR. All patients with MR grade 2C or more underwent outpatient preoperative transesophageal echocardiography (TEE) to establish the mechanism of MR. Criteria for IMR were presence of systolic restrictive leaflet motion, with or without annulus dilatation and absence of other mitral valve pathology. Patients with ischemic MR grade 3C or 4C were scheduled for RMA with or without CABG. In patients who were scheduled for CABG anyway, with MR grade 2C or fluctuating MR, an intraoperative loading test was performed by canulation of the ascending aorta and increasing the pulmonary capillary wedge pressure with 15 mmHg compared to baseline value [2, 10] by rapid filling through the aortic cannula, prior to the institution of cardiopulmonary bypass. If MR increased to grade 3C or 4C patients underwent RMA.
Patients with coexisting aortic valve disease or previous aortic valve surgery and patients who had concomitant surgery for LV aneurysm were excluded from this study, as were patients with functional MR based on idiopathic dilating cardiomyopathy. Patients with organic mitral valve abnormalities were also excluded. There were no patients excluded based on critical preoperative status; mean logistic EuroSCORE was 11.0G10.7 (range 2-63). Fourteen (16.1%) patients had their last myocardial infarction 6 weeks or less before surgery, three patients were ventilator-dependent preoperatively, three had IABP support and eight had intravenous inotropic drugs. Preoperative clinical and angiographic characteristics are presented in Table 1 .
Mean preoperative MR grade was 3.1G0.5 (86.2% of patients had grade 3C or 4C). Mean LV ejection fraction was 32G10%, baseline LV end-systolic dimension (LVESD) was 52G8 mm, LV end-diastolic dimension (LVEDD) was 64G8 mm.
Operative technique
All operations were performed through midline sternotomy on normothermic cardiopulmonary bypass with intermittent antegrade warm blood cardioplegia. An intraoperative loading-test was performed in 16 (18.4%) patients with grade 2C or fluctuating MR, and showed increase to grade 3C or 4C in all cases.
CABG was performed in 75 (86.2%) patients; 12 patients did not undergo revascularization because of absence of angina and of ischemia on myocardial scintigraphy or because of patent coronary artery bypass grafts in redo operations. Revascularization of the anterior myocardium was always achieved with the LITA. For other territories, the RITA was used in patients under the age of 65 with good target vessels-either as an in situ graft or as a free graft with proximal anastomosis to the LITA. In other cases, the saphenous vein was used. In one patient, the gastroepiploic artery was used for the inferior wall.
Exposure of the mitral valve was through a vertical transseptal approach. Mitral annuloplasty ring size (Carpentier Edwards Physioring, Edwards Lifesciences, Irving, CA, USA) was determined by standard measurement of the intertrigonal distance and anterior leaflet height, and then stringent downsizing by two ring sizes was performed. The rings were anchored using multiple (14-16) deep u-shaped stitches of Ethibond 2-0 (Ethicon, Inc., Somerville, NJ, USA) or Ti-Cron 2-0 (Syneture, Norwalk, CT, USA). Ninety-three percent of the rings were size 28 or less (mean size 26). Tricuspid ring annuloplasty was performed in 16 (18.4%) patients when annulus enlargement had been observed on echocardiography (S40 mm), or was present on intraoperative inspection. A Carpentier Edwards Classic annuloplasty ring or Edwards MC3 annuloplasty ring (both manufactured by Edwards Lifesciences, Irving, CA, USA) was used. In six (6.9%) patients with persistent or chronic atrial fibrillation endocardial unipolar radiofrequency ablation was done with the Cardioblate device (Medtronic, Inc., Minneapolis, MN, USA), as described by Melo et al. [11] . One patient underwent simultaneous left upper lobe lobectomy for non-small cell lung carcinoma. Mean cardiopulmonary bypass time and aortic cross-clamping time were 189G52 and 125G37 min, respectively. Surgical aspects are summarized in Table 2 .
Intra-and post-operative echocardiography and clinical follow-up
Intra-operative TEE was used in all patients to evaluate residual MR, mitral valve gradient, mitral valve area and leaflet coaptation height (defined as the length of coaptation of the anterior and posterior leaflet at the level A2-P2 in end-systole), residual tricuspid regurgitation (TR) and LV function. We aimed at no MR and a minimum coaptation height of 8 mm.
Before discharge, TTE was used to determine left atrial and LV dimensions, severity of MR and TR, and mitral valve gradient. All patients were rescheduled for TTE between 3 and 6 months following surgery and after 18 months. All echocardiograms were analyzed in random order by two combined readers, blinded to clinical data and to the timing of the study. Clinical follow-up was achieved at the outpatient clinic concurrent with TTE, and by telephone interviews in August 2004. NYHA functional class was assessed, events scored included reoperation; balloon angioplasty; myocardial infarction; readmission for heart failure; thrombo-embolic complications and endocarditis. Surface electrocardiograms were made to assess cardiac rhythm.
Statistical analysis
Continuous data are expressed as meanGstandard deviation unless otherwise stated, and compared using Student's t-test for paired and unpaired data when appropriate. Proportions were compared by c 2 analysis with Yates' correction. Actuarial survival over time and event-free survival were analyzed using the method of Kaplan-Meier. Univariate and multivariate logistic regression analyses were performed to characterize predictors of reverse left ventricular remodeling. Variables considered were: gender, age, baseline NYHA class, left ventricular ejection fraction, severity of MR, left atrial dimension, left ventricular endsystolic and end-diastolic dimensions. Optimal cut-off values of LVESD and LVEDD to predict reverse remodeling were determined by receiver-operating characteristic (ROC) curve analysis. The optimal cut-off value was defined as that providing maximal accuracy to distinguish between responders and non-responders. For all tests, a P value !0.05 was considered significant. SPSS statistical software (SPSS version 11.5, SPSS, Inc., Chicago, IL, USA) was used for calculations.
Results
Mitral valve repair could be achieved in all patients, irrespective of the degree of leaflet tethering. Intraoperative post-repair TEE showed absence of MR in 78 (90%) patients and trace or grade 1C MR in 9 (10%); mean MR grade was 0.2G0.3. Leaflet coaptation height was 8G2 mm; no patient showed mitral stenosis (mean transvalvular gradient 2.9G1.1 mmHg, mean valvular area 2.8G0.6 cm 2 ).
Immediate outcome
There were no intra-operative deaths. In the postoperative course, three (3.7%) patients required intra-aortic balloon counterpulsation because of low cardiac output. Six (6.9%) patients needed temporary dialysis for renal failure. One patient sustained a myocardial infarction (for which he underwent emergency redo coronary revascularization). There were no neurologic complications. One (1.1%) patient developed mediastinitis. Mean ICU stay was 5G3 days.
Early mortality (30-day mortality and in-hospital mortality when length of stay after surgery exceeded 30 days) was 8.0% (seven patients). Causes of death were: intractable ventricular arrhythmia (nZ2), multi-organ failure (MOF) following myocardial infarction (1), intractable vasoplegia (1), septicemia and MOF following duodenal perforation after insertion of feeding tube (1), RV rupture following mediastinitis (1) and pneumonia following exacerbation of leukemia (1).
Long-term follow-up
Follow-up for surviving patients was complete. Mean duration of clinical follow-up was 29G14 months (range 6-54 months). Six patients (7.5%) died during follow-up of congestive heart failure (1), ventricular arrhythmia (1), traumatic intracranial hemorrhage (1) and malignant disease (3). Therefore, actuarial survival at 2 years was 85.6% (Fig. 1) .
Two patients needed reoperation for recurrent MR. The first patient, with dilated ischemic cardiomyopathy had no MR directly after surgery with 6 mm leaflet coaptation (initial ring size 28). Over time, MR gradually increased with progressive heart failure. After 12 months, she was reoperated and a size 26 annuloplasty ring was inserted, with no MR 17 months after her second operation. The other patient, an acromegalic man, had a size 32 ring without regurgitation initially. After 6 months, he was readmitted for congestive heart failure with massive MR. On reoperation, a partial ring dehiscence was observed at the posterior commissure. Refixation of the ring was successful and the patient is asymptomatic 17 months later. Two patients underwent PTCA during the follow-up period, and four were readmitted for congestive heart failure. NYHA class improved from 3.0G0.9 to 1.3G0.5 (P!0.01), with 18 patients in NYHA class II and 1 patient in class III.
Mitral regurgitation and LV remodeling at long-term follow-up
At 18 months follow-up, mean MR grade was 0.6G0.6 (MR trace or grade 1C in 28 patients and grade 2C in 5).
Left atrial dimension decreased from 54G6 mm at baseline measurement to 48G6 mm at 18 months (P!0.01). LVESD decreased from 52G8 to 44G11 mm (P!0.01), and LVEDD decreased from 64G8 to 58G10 mm (P!0.01).
Forty-six (60.5%) surviving patients demonstrated significant reverse LV remodeling, considering a 10% reduction in LVEDD as significant. In this subset of patients, LVEDD decreased from 60G5 to 51G4 mm (P!0.01), whereas LVESD changed from 47G6 to 37G5 mm (P!0.01). Echocardiographic data are presented in Table 3 .
Baseline characteristics for patients with and without LV reverse remodeling were comparable, except for baseline LVEDD (71G6 versus 60G5 mm, P!0.01) and LVESD (58G8 versus 47G6 mm, P!0.01).
ROC curve analysis showed that the optimal cut-off value for LVESD to predict reverse remodeling was 51 mm; application of this cut-off value yielded a predictive sensitivity and specificity of 81% (area under the curve 0.85, see Fig. 2 ). ROC curve analysis on LVEDD identified an optimal cut-off value of 65 mm, which yielded a sensitivity and specificity of 89% (area under the curve 0.92, see Fig. 3 ) to predict reverse left ventricular remodeling. Multivariate analysis demonstrated that LVEDD was the single best predictor of reverse remodeling.
Discussion
IMR is a complication of coronary artery disease that is frequently overlooked, in spite of its prevalence of 19% in post-infarction patients [12] . The high prevalence of IMR combined with a dismal prognosis warrants a search for its presence in patients at risk. Since IMR is a form of functional MR, preload and afterload conditions influence the severity of MR present on echocardiographic examination. Therefore, patients with CAD who present with signs and symptoms of heart failure, especially following (inferoposterior) myocardial infarction, should undergo a sound workup to exclude IMR.
Patients with chronic IMR represent a heterogeneous group when it comes to LV dysfunction; the spectrum of LV performance comprises both well-preserved ventricles with near-normal ejection fractions, and dilated cardiomyopathies with ejection fraction below 10%. However, echocardiographic studies from the Mayo Clinic have shown that the presence and degree of IMR is unrelated to the severity of LV dysfunction; local LV remodeling leads to excess valvular tenting independent of global LV remodeling [13] .
IMR should be treated with mitral valve surgery. Earlier reports from a cohort of 58 patients [5, 6] who received CABG alone in the presence of grade 3C MR between 1977 and 1983, compared with 20 patients who underwent CABG and mitral valve replacement, showed worse outcome in the latter group. This study has given many surgeons an argument against an intervention on the valve rather than CABG alone in IMR. However, the cohorts were not comparable, as there were large differences between ischemia being the cause of MR (74% versus 30% in the control group), the mean ejection fraction was very high (53%) and only 10% of patients were in NYHA class III or IV.
A report by Tolis et al. [14] suggests that MR grade is reduced following isolated CABG in patients with 'mild-tomoderate' IMR and ischemic cardiomyopathy (mean EF 22.4%, range 10-30%). However, 18 out of 49 patients had grade 1C MR, and 6 had grade 3C. Follow-up is based on 26 out of 49 patients, and gives only a mean value for residual MR without a distribution. Aklog et al. [7] have shown that CABG alone for moderate IMR leaves many patients with significant residual MR and is therefore an inadequate approach. Harris [15] has reported on 176 patients with CAD and grade 2C or 3C IMR, of whom 142 underwent CABG alone and 34 CABG with mitral valve repair or replacement. Patients in NYHA class III or IV showed superior late survival when the mitral valve was operated, and MR grade was increasing over time in the CABG group while it was stable in the CABGCvalve group. However, operative mortality was lower in the CABG group (9 versus 21%).
The reverse LV remodeling observed in this study is obvious, and largely a consequence of the disappearance of mitral regurgitation and LV volume overload. The design of our study does not allow to differentiate between the effects of revascularization (of hibernating myocardium) versus those of mitral valvuloplasty on reverse LV remodeling. Preoperative medical therapy was continued without modification after surgery for the duration of the study. In particular, the use and dosage of ACE-inhibiting agents was not changed during the course of follow-up, and therefore its influence on LV reverse remodeling in this patient group is negligable. Additional tricuspid annuloplasty-performed whenever annulus diameter equalled or exceeded 40 mmis thought to be beneficial in that it optimizes the filling of the left ventricle which is particularly useful in patients with impaired diastolic function.
Our operative and 30-day mortality of 8.0% is acceptable, when related to EuroSCORE and to other series. Comparing operative mortality scores for treatment of IMR requires again a strict look at patient selection. Strictly speaking, IMR can also be applied to patients with papillary muscle rupture, a patient group with an obviously dismal prognosis. A large series from Cleveland [16] has shown 13% overall 30-day mortality in all IMR cases (including ruptured papillary muscle and including MV replacement); in a 'better-risk' group, mortality with MV repair was 6%. Grossi [17] has reported from a similar group of patients, showing 10% operative mortality for repair. Our series is restricted to patients with functional MR only, although we did not exclude patients because of critical preoperative state as can be seen from the number of patients requiring ventilatory or inotropic support preoperatively. We have reported on the use of restrictive mitral annuloplasty in the emergency setting in IMR patients with acute deterioration with intact papillary muscle [18] .
Calafiore [19] recently reported a 3.9% 30-day mortality (2.4% for MV repair) in IMR. Long-term follow-up shows excellent survival and improvement in functional status.
Several studies report the use of restrictive mitral annuloplasty in functional IMR [8, 16] . Calafiore chooses a posterior annuloplasty only [19] , whereas he promotes MV replacement in cases with extensive leaflet tethering (as measured by the distance from the coaptation point up to the mitral annulus). We prefer a true annuloplasty to really reduce the anterior-posterior distance of the annulus and enforce at least 8 mm coaptation height. In all cases, even in the presence of extensive tethering, this approach was successful with stringent downsizing by two ring sizes. The technique is simple and does not add much time to myocardial ischemia. The durability of this technique is illustrated by the sequential echocardiograms showing absence of residual MR at 18 months. We never performed mitral valve replacement. The fear of systolic anterior motion following downsizing is unnecessary, because of the widened aorto-mitral angle in this type of pathology. We never encountered elevated transmitral gradients, because the leaflet tissue is normal in this type of pathology.
The most important finding in this study is, that preoperative LV dimensions predict the likelihood of reverse remodeling, which is the ultimate goal of the surgeon. Reverse remodeling decreases the stress on the valvular and subvalvular apparatus and therefore consolidates the result. In our series, the chance of reverse remodeling to occur is low when preoperative LVEDD exceeds 65 mm and/or LVESD is more than 51 mm. Even in the absence of recurrent MR, a left ventricle with dilatation beyond these cut-off values does not achieve reverse remodeling, suggesting that the extent of disease of the left ventricle is the limiting factor in the process of reverse remodeling. Of interest, 8 of 13 (61.5%) patients who died in this series had an LVEDDO 65 mm, and 7 of 13 patients (53.8%) had an LVESDO51 mm.
Restrictive mitral annuloplasty with or without CABG can be applied in patients with ischemic mitral regurgitation with an acceptable operative risk. Clinical outcome at 2 years follow-up remains favorable. Recurrent MR is seldom observed if proper stringent downsizing is performed, and LV reverse remodeling occurs within the limitations set by the extent of preoperative LV dilatation.
The finding that baseline LV dimensions seem to play a key role in the likelihood of reverse remodeling indicates that CABG with RMA are not sufficient to ensure a favorable long-term outcome in patients with LV dimensions beyond the cut-off value. We now apply a CorCap cardiac support device (Acorn Cardiovascular, Inc., St Paul, MN, USA) in all patients with IMR and dilated cardiomyopathy with LVEDDO 65 mm. Another approach to these patients might be found in a more aggressive left ventricular restoration surgery, especially when LVEDDO80 mm [20] . Future follow-up will show whether this strategy will contribute to LV reverse remodeling in this subset of patients. A close follow-up of patients that approach these LV dimensions on preoperative evaluation is necessary to observe further dilatation.
